PubMed=11004682; DOI=10.1002/1097-0215(20001015)88:2<287::aid-ijc22>3.0.CO;2-U
Briz O., Serrano M.A., Macias R.I.R., Marin J.J.G.
Overcoming cisplatin resistance in vitro by a free and liposome-encapsulated bile acid derivative: BAMET-R2.
Int. J. Cancer 88:287-292(2000)

PubMed=12606785; DOI=10.1124/mol.63.3.742
Briz O., Macias R.I.R., Vallejo M., Silva A., Serrano M.A., Marin J.J.G.
Usefulness of liposomes loaded with cytostatic bile acid derivatives to circumvent chemotherapy resistance of enterohepatic tumors.
Mol. Pharmacol. 63:742-750(2003)

PubMed=25193168; DOI=10.1074/mcp.M113.037291
Hornburg D., Drepper C., Butter F., Meissner F., Sendtner M., Mann M.
Deep proteomic evaluation of primary and cell line motoneuron disease models delineates major differences in neuronal characteristics.
Mol. Cell. Proteomics 13:3410-3420(2014)

PubMed=26280412; DOI=10.1038/nbt.3327
Humphrey S.J., Azimifar S.B., Mann M.
High-throughput phosphoproteomics reveals in vivo insulin signaling dynamics.
Nat. Biotechnol. 33:990-995(2015)

PubMed=28152020; DOI=10.1371/journal.pone.0171215
Lacoste B., Raymond V.-A., Cassim S., Lapierre P., Bilodeau M.
Highly tumorigenic hepatocellular carcinoma cell line with cancer stem cell-like properties.
PLoS ONE 12:E0171215-E0171215(2017)

PubMed=31220119; DOI=10.1371/journal.pone.0218412
Almeida J.L., Dakic A., Kindig K., Kone M., Letham D.L.D., Langdon S., Peat R., Holding-Pillai J., Hall E.M., Ladd M., Shaffer M.D., Berg H., Li J.-L., Wigger G., Lund S., Steffen C.R., Fransway B.B., Geraghty B., Natoli M., Bauer B., Gollin S.M., Lewis D.W., Reid Y.A.
Interlaboratory study to validate a STR profiling method for intraspecies identification of mouse cell lines.
PLoS ONE 14:E0218412-E0218412(2019)